CB Insights
Technology Market Intelligence
Technology Market Intelligence
US Stem Cell is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.
Company (IPO / Went public)
Phone: 954-835-1500
1560 Sawgrass Corporate Parkway
4th Floor
Sunrise, 33323
Florida, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| US Stem Cell | $43M | Feb 20, 2008 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| JCI Ventures | Corporate Venture | San Mateo, California, United States | Series A |
| Astri Group | Series D | ||
| Advent-Morro Equity Partners | Private Equity | San Juan, Puerto Rico | Series D |
| Ascent Private Equity | Unattributed VC - II, Series D, Unattributed VC | ||
| Guidant Compass Group | Corporate Venture | United States | Series D, Unattributed VC |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Method of enhancing myogenesis by electrical stimulation | Mar 28, 2005 | Jan 27, 2009 | Patent |
